Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats

被引:24
作者
Cameron, KO [1 ]
Lefker, BA [1 ]
Chu-Moyer, MY [1 ]
Crawford, DT [1 ]
Jardine, PD [1 ]
DeNinno, SL [1 ]
Gilbert, S [1 ]
Grasser, WA [1 ]
Ke, HZ [1 ]
Lu, BH [1 ]
Owen, TA [1 ]
Paralkar, VM [1 ]
Qi, H [1 ]
Scott, DO [1 ]
Thompson, DD [1 ]
Tjoa, CM [1 ]
Zawistoski, MP [1 ]
机构
[1] Pfizer Global Res & Dev, Groton Labs, Dept Cardiovasc & Metab Dis, Groton, CT 06340 USA
关键词
bone anabolic agent; EP4; EP2; prostaglandin; lactam; osteoporosis;
D O I
10.1016/j.bmcl.2006.01.018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Heptanoic acid lactams. exemplified by 2, were identified as highly selective EP4 agonists via high throughput screening. Lead optimization led to the identification of lactams with a 30-fold increase in EP4 potency in vitro. Compounds demonstrated robust bone anabolic effects when administered in vivo in rat models of osteoporosis. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1799 / 1802
页数:4
相关论文
共 22 条
[1]  
*AM CHEM SOC, 2003, MEDI167 AM CHEM SOC
[2]   Discovery of a potent and selective agonist of the prostaglandin EP4 receptor [J].
Billot, X ;
Chateauneuf, A ;
Chauret, N ;
Denis, D ;
Greig, G ;
Mathieu, MC ;
Metters, KM ;
Slipetz, DM ;
Young, RN .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) :1129-1132
[3]  
CAMERON KO, 2002, 224 NAT M AM CHEM SO
[4]  
CAMERON KO, Patent No. 6552067
[5]  
CAMERON KO, 2003, 226 NAT M AM CHEM SO
[6]  
CAMERON KO, Patent No. 6737437
[7]  
COLEMAN RA, 1990, COMPREHENSIVE MED CH, V3, P643
[8]  
Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P1987, DOI 10.1002/(SICI)1521-3773(19980817)37:15<1986::AID-ANIE1986>3.0.CO
[9]  
2-Z
[10]   A STABLE AND EASILY PREPARED CATALYST FOR THE ENANTIOSELECTIVE REDUCTION OF KETONES - APPLICATIONS TO MULTISTEP SYNTHESES [J].
COREY, EJ ;
BAKSHI, RK ;
SHIBATA, S ;
CHEN, CP ;
SINGH, VK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (25) :7925-7926